Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Staging
12 results:

  • 1. Prognostic significances of pd-l1- and CTLA-4-positive T cells and positive correlations of immunosuppressive marker expression between cancer tissue and peripheral blood in patients with gastric cancer.
    Lee KH; Kim SJ; Woo JS; Lee SY; Jhun J; Moon J; Jung YJ; Cho ML; Song KY
    Front Immunol; 2023; 14():1138743. PubMed ID: 37153541
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Gene Expression Analysis of Immune Regulatory Genes in Circulating Tumour Cells and Peripheral Blood Mononuclear Cells in Patients with colorectal Carcinoma.
    Aktar S; Hamid FB; Gamage SMK; Cheng T; Parkneshan N; Lu CT; Islam F; Gopalan V; Lam AK
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902476
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A high density of pd-l1-expressing immune cells is significantly correlated with favorable disease free survival in nonmetastatic colorectal cancer.
    Kuo YT; Liao CK; Chen TC; Lai CC; Chiang SF; Chiang JM
    Medicine (Baltimore); 2022 Jan; 101(3):e28573. PubMed ID: 35060518
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Anorectal melanoma and gene analysis of personalized adjuvant therapy: a case report.
    Cai X; Zhu X
    Ann Palliat Med; 2021 Oct; 10(10):11216-11220. PubMed ID: 34763479
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Overexpression of transposable elements is associated with immune evasion and poor outcome in colorectal cancer.
    Zhu X; Fang H; Gladysz K; Barbour JA; Wong JWH
    Eur J Cancer; 2021 Nov; 157():94-107. PubMed ID: 34492588
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinicopathological characteristics of type 2 diabetes mellitus complicated with colorectal cancer].
    Han ZH; Chen JJ; Feng N; Niu PF; Song C; Gao ZY; Gao QK; Ji DB; Wang WB; Lei FM; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):966-971. PubMed ID: 31630495
    [No Abstract]    [Full Text] [Related]  

  • 7. CCRK is a novel signalling hub exploitable in cancer immunotherapy.
    Mok MT; Zhou J; Tang W; Zeng X; Oliver AW; Ward SE; Cheng AS
    Pharmacol Ther; 2018 Jun; 186():138-151. PubMed ID: 29360538
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Implications of the tumor immune microenvironment for staging and therapeutics.
    Taube JM; Galon J; Sholl LM; Rodig SJ; Cottrell TR; Giraldo NA; Baras AS; Patel SS; Anders RA; Rimm DL; Cimino-Mathews A
    Mod Pathol; 2018 Feb; 31(2):214-234. PubMed ID: 29192647
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors.
    Marisa L; Svrcek M; Collura A; Becht E; Cervera P; Wanherdrick K; Buhard O; Goloudina A; Jonchère V; Selves J; Milano G; Guenot D; Cohen R; Colas C; Laurent-Puig P; Olschwang S; Lefèvre JH; Parc Y; Boige V; Lepage C; André T; Fléjou JF; Dérangère V; Ghiringhelli F; de Reynies A; Duval A
    J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922790
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immunoprofiling as a predictor of patient's response to cancer therapy-promises and challenges.
    Bethmann D; Feng Z; Fox BA
    Curr Opin Immunol; 2017 Apr; 45():60-72. PubMed ID: 28222333
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Potential role of nuclear pd-l1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients.
    Satelli A; Batth IS; Brownlee Z; Rojas C; Meng QH; Kopetz S; Li S
    Sci Rep; 2016 Jul; 6():28910. PubMed ID: 27363678
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Integrative Analyses of colorectal cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability.
    Mlecnik B; Bindea G; Angell HK; Maby P; Angelova M; Tougeron D; Church SE; Lafontaine L; Fischer M; Fredriksen T; Sasso M; Bilocq AM; Kirilovsky A; Obenauf AC; Hamieh M; Berger A; Bruneval P; Tuech JJ; Sabourin JC; Le Pessot F; Mauillon J; Rafii A; Laurent-Puig P; Speicher MR; Trajanoski Z; Michel P; Sesboüe R; Frebourg T; Pagès F; Valge-Archer V; Latouche JB; Galon J
    Immunity; 2016 Mar; 44(3):698-711. PubMed ID: 26982367
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.